Get the Stockscreener App
2.455
4.68%
0.105
Health Catalyst Inc stock is traded at $2.455, with a volume of 208.05K.
It is up +4.68% in the last 24 hours and up +4.24% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$2.35
Open:
$2.39
24h Volume:
208.05K
Relative Volume:
0.33
Market Cap:
$173.64M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-1.6367
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+4.68%
1M Performance:
+4.24%
6M Performance:
-31.67%
1Y Performance:
-65.30%
1-Day Range:
$2.39
$2.49
1-Week Range:
$2.32
$2.5113
52-Week Range:
$2.015
$7.65
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.455 | 166.22M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
224.67 | 36.47B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
67.01 | 11.47B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
44.97 | 8.22B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.58 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.59 | 6.76B | 11.99B | 24.18M | 234.31M | 0.2956 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Is Health Catalyst Inc. stock a buy before product launchesJuly 2025 Update & Weekly High Momentum Picks - ulpravda.ru
Will Health Catalyst Inc. (2YP) stock outperform global peersJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Why Health Catalyst Inc. stock is a must watch in 2025July 2025 EndofMonth & Expert Curated Trade Setup Alerts - Улправда
Can Health Catalyst Inc. stock rebound after recent weakness2025 AllTime Highs & Verified Technical Trade Signals - DonanımHaber
Death Cross: How Health Catalyst Inc. stock trades during market volatility2025 Market Outlook & Community Shared Stock Ideas - Улправда
Is Health Catalyst Inc. (2YP) stock attractive for growth fundsTrade Analysis Summary & Community Supported Trade Ideas - Улправда
HubSpot, nCino, Rapid7, and Health Catalyst Stocks Trade Down, What You Need To Know - Finviz
New Program Aims to Strengthen Community Health Tech in NWA - Philanthropy News Digest
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares - MarketBeat
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock - MarketBeat
Dir Larson-Green Sells 47,997 ($128.3K) Of Health Catalyst Inc [HCAT] - TradingView — Track All Markets
Health Catalyst's Market Cap Drops To US$190m Leaving Insiders With Losses - simplywall.st
What technical patterns form on Health Catalyst Inc. (2YP) stock chartsWeekly Market Outlook & Precise Buy Zone Tips - Newser
How Health Catalyst Inc. (2YP) stock behaves in tightening cyclesLong Setup & Weekly Market Pulse Alerts - Newser
Is Health Catalyst Inc. (2YP) stock positioned for digital growth era2025 Market Overview & Fast Moving Stock Watchlists - Newser
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is Health Catalyst Inc. (2YP) stock supported by free cash flowWeekly Investment Summary & Stock Timing and Entry Methods - Newser
Why Health Catalyst Inc stock is a must watch in 2025 - BỘ NỘI VỤ
Officer Freeman Surrenders 16,401 Of Health Catalyst Inc [HCAT] - TradingView
Will Health Catalyst Inc. (2YP) stock sustain bullish trend into 20252025 Technical Overview & Weekly High Return Forecasts - Newser
Health Catalyst appoints largest shareholder’s CEO to board By Investing.com - Investing.com Canada
Is Health Catalyst Inc. (2YP) stock expanding market penetrationJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Health Catalyst Q3 2025 Earnings Preview - MSN
Matt Arens, CEO and founder of Health Catalyst's largest shareholder, First Light Asset Management, joins board of directors - marketscreener.com
Matt Arens, CEO And Founder Of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board Of Directors - TradingView
Health Catalyst appoints largest shareholder’s CEO to board - Investing.com
Health Catalyst Appoints New Board Member Matt Arens - TipRanks
Health Catalyst Appoints Matt Arens to Board of Directors - TradingView — Track All Markets
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors - PR Newswire
Will Health Catalyst Inc. (2YP) stock justify high valuationWeekly Profit Recap & AI Driven Price Forecasts - Newser
Will Health Catalyst Inc. (2YP) stock gain from lower interest ratesTrade Signal Summary & Entry Point Strategy Guides - Newser
Officer Ross Files To Sell 4,793 Of Health Catalyst Inc [HCAT] - TradingView — Track All Markets
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2025 Earnings Call Transcript - MSN
Can Health Catalyst Inc. stock deliver strong Q4 earnings2025 Dividend Review & Fast Gain Stock Trading Tips - BỘ NỘI VỤ
Health Catalyst and Unity Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst and ON24 Stocks Trade Up, What You Need To Know - The Globe and Mail
Can Health Catalyst Inc. (2YP) stock hold up in economic slowdownQuarterly Earnings Summary & Fast Exit and Entry Strategy Plans - newser.com
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know - The Globe and Mail
Why Health Catalyst Inc. stock could outperform in 2025Breakout Watch & Capital Efficient Trade Techniques - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathQuarterly Earnings Summary & Intraday High Probability Setup Alerts - newser.com
Health Catalyst (HCAT) Price Target Decreased by 11.25% to 4.02 - MSN
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.98%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):